Vimarsana
Biggest News Aggregation in the World

Scan Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scan Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scan Research Today - Breaking & Trending Today

The 'Mandela Effect:' A Psychologist Explains Collective False Memories - Vimarsana News

The 'Mandela Effect:' A Psychologist Explains Collective False Memories

Research highlights how collective false memories, a mystery that pushes the boundaries of science, challenge our understanding and defy explanation.

Source: forbes.com
Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States - Vimarsana News

Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States

Using data from over 16 million people in the United States, Angela Y Chang and colleagues explore how multimorbidity, when considering 63 different conditions, influences health care expenditure.

Source: plos.org
Apixaban Useful for Anticoagulation Therapy for Older Adults with Dementia, Atrial Fibrillation - Vimarsana News

Apixaban Useful for Anticoagulation Therapy for Older Adults with Dementia, Atrial Fibrillation

New data suggest that older dementia patients who also have dementia are recommended to take apixaban, an oral anticoagulant.

TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis - Vimarsana News

TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was...

Asymptomatic C. difficile Carriers May Infect Their Families - Vimarsana News

Asymptomatic C. difficile Carriers May Infect Their Families

Hospitalized asymptomatic C. difficile carriers may infect people they live with after they return home, new research suggests.